Logo image of YXT

YXT.COM GROUP HOLDING LTD (YXT) Stock Fundamental Analysis

NASDAQ:YXT - Nasdaq - US9887401068 - ADR - Currency: USD

0.499  0 (-0.2%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to YXT. YXT was compared to 281 industry peers in the Software industry. YXT has a bad profitability rating. Also its financial health evaluation is rather negative. YXT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

YXT had positive earnings in the past year.
YXT Yearly Net Income VS EBIT VS OCF VS FCFYXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

Looking at the Return On Assets, with a value of 34.54%, YXT belongs to the top of the industry, outperforming 98.58% of the companies in the same industry.
The Return On Equity of YXT (124.95%) is better than 99.29% of its industry peers.
Industry RankSector Rank
ROA 34.54%
ROE 124.95%
ROIC N/A
ROA(3y)-29.3%
ROA(5y)N/A
ROE(3y)-134.77%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
YXT Yearly ROA, ROE, ROICYXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

YXT has a Profit Margin of 85.73%. This is amongst the best in the industry. YXT outperforms 97.51% of its industry peers.
YXT has a Gross Margin (61.80%) which is in line with its industry peers.
YXT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 85.73%
GM 61.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5YN/A
YXT Yearly Profit, Operating, Gross MarginsYXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -100 -200 -300

1

2. Health

2.1 Basic Checks

YXT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, YXT has about the same amount of shares outstanding.
Compared to 1 year ago, YXT has a worse debt to assets ratio.
YXT Yearly Shares OutstandingYXT Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M
YXT Yearly Total Debt VS Total AssetsYXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 500M 1B

2.2 Solvency

YXT has an Altman-Z score of -5.61. This is a bad value and indicates that YXT is not financially healthy and even has some risk of bankruptcy.
YXT's Altman-Z score of -5.61 is on the low side compared to the rest of the industry. YXT is outperformed by 83.63% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that YXT is somewhat dependend on debt financing.
YXT has a worse Debt to Equity ratio (0.55) than 66.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Altman-Z -5.61
ROIC/WACCN/A
WACC8.45%
YXT Yearly LT Debt VS Equity VS FCFYXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M -200M 400M -400M 600M 800M

2.3 Liquidity

YXT has a Current Ratio of 1.21. This is a normal value and indicates that YXT is financially healthy and should not expect problems in meeting its short term obligations.
YXT has a worse Current ratio (1.21) than 64.41% of its industry peers.
YXT has a Quick Ratio of 1.21. This is a normal value and indicates that YXT is financially healthy and should not expect problems in meeting its short term obligations.
YXT's Quick ratio of 1.21 is on the low side compared to the rest of the industry. YXT is outperformed by 64.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.21
YXT Yearly Current Assets VS Current LiabilitesYXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M 800M 1B

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 223.49% over the past year.
YXT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.89%.
Measured over the past years, YXT shows a decrease in Revenue. The Revenue has been decreasing by -2.83% on average per year.
EPS 1Y (TTM)223.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.43%
Revenue 1Y (TTM)-21.89%
Revenue growth 3Y-2.83%
Revenue growth 5YN/A
Sales Q2Q%-78.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
YXT Yearly Revenue VS EstimatesYXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 100M 200M 300M 400M

2

4. Valuation

4.1 Price/Earnings Ratio

YXT is valuated cheaply with a Price/Earnings ratio of 0.77.
Based on the Price/Earnings ratio, YXT is valued cheaply inside the industry as 99.29% of the companies are valued more expensively.
YXT is valuated cheaply when we compare the Price/Earnings ratio to 28.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.77
Fwd PE N/A
YXT Price Earnings VS Forward Price EarningsYXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
YXT Per share dataYXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

YXT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

YXT.COM GROUP HOLDING LTD

NASDAQ:YXT (4/28/2025, 9:30:43 AM)

0.499

0 (-0.2%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-27 2025-03-27/amc
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap29.98M
AnalystsN/A
Price TargetN/A
Short Float %0.05%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.77
Fwd PE N/A
P/S 0.66
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 3.88
EV/EBITDA N/A
EPS(TTM)0.65
EY130.26%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.76
BVpS0.52
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 34.54%
ROE 124.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 85.73%
GM 61.8%
FCFM N/A
ROA(3y)-29.3%
ROA(5y)N/A
ROE(3y)-134.77%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 1.21
Altman-Z -5.61
F-ScoreN/A
WACC8.45%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)223.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.89%
Revenue growth 3Y-2.83%
Revenue growth 5YN/A
Sales Q2Q%-78.9%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A